Cinepazide

DB12123InvestigationalSmall molecule

Cinepazide has been used in trials studying the treatment of Ischemic Stroke.

Chemical structure of Cinepazide
Formula / weight
C22H31N3O5 · 417.506 g/mol (avg)

Resolves to

Compound
UNII67Y4P5C84XCAS23887-46-9ChEMBLCHEMBL1874750ChEBI135676PubChem5282459
Clinical / RWD
ATCC04AX27
Structure
InChIKeyRCUDFXMNPQNBDU-VOTSOKGWSA-NSMILESCOC1=CC(\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2)=CC(OC)=C1OC

What you can answer from here — as of August 30, 2026

3Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in

Which companies are running trials of Cinepazide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In